6000 patients at discounted $200 per month (current price around $350-$500 per bottle per month)$1.2m per month$14.4m annualised.Then when volume is ramped up and export sales plenty more upside.Plus upside for Canada revenue.Any thoughts on valuation when this is achieved?
- Forums
- ASX - By Stock
- EPN
- Potential $14m revenue
Potential $14m revenue
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EPN (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EPN (ASX) Chart |
Day chart unavailable
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online